Association Between Delayed Diagnosis Of Breast Cancer And Its Degree Of Invasiveness Among The Patients In Tertiary Care Hospital Of Karachi
DOI:
https://doi.org/10.51985/JBUMDC2019114Abstract
Objective: To find the association between delayed diagnosis of breast cancer over the degree of invasiveness for each
of the immune-histochmically defined molecular type of invasive ductal carcinoma among the patient in tertiary care
hospital of Karachi.
Study Design and Setting: A cross sectional study was conducted on 153 post mastectomy patients in a time frame of
two years at Bait-ul-Sukoon Hospital who had their immunohistochemistry workup.
Methodology: The patients included in the research were diagnosed cases of breast cancer; had post-mastectomy with
their histopathological and immunochemistry status work up reports. In addition to demographic variables; the histopathological
report of specimen, histological tumor type and grade, invasive tumor size, axillary lymph node status, Paget’s disease and
stage of the disease were recorded from the histopathological report however ER, PR and Her 2 neu receptor statuses were
confirmed via immunochemistry report. Volume of the tumor was calculated using the following formula V = (W2 × L)/2
Convenient sampling was applied and the data was analyzed on SPSS 20.0 with CI-95% and P=0.05.
Results- All 153 patients reported because of unpleasant symptoms.47.1% of the participants presented with LT while the
remaining 52.9% were grouped as NLT. The association of molecular type with stage at mastectomy was statistically
significant (P=0.015) in the ERG. Her-2 enriched variant shows that there was a moderate positive statistically significant
relationship between log of total delay and log of tumor volume +2.
Conclusion: Delay in diagnosis due to lack of screening modalities, lesser awareness among low socioeconomic groups
and inaccessibility to tertiary care were not the major causes of aggressive tumors at diagnosis in developing countries,
instead all the major known risk factors influence to the tumor burden collectively .
References
- JemalA, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer JClin. 2011; 61(2): 69–90.
- Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014;11(2):101-15.
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11;
- Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg. 2007;31(5):1031-40.
- Shibuya K, Mathers CD, Boschi PC, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site. II. Results for the global burden of disease 2000. BMC Cancer. 2002;2:37.
- Begum N. Breast Cancer in Pakistan: A Looming Epidemic.
J Coll Physicians Surg Pak. 2018;28(2):87-8.
- Sohail S, Alam SN. Breast cancer in Pakistan-awareness and early detection. J Coll PhysiciansSurg Pak. 2007; 17(12):711- 2.
- Zaheer S, Shah N, Maqbool SA, Soomro NM. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004-2005. BMC Public Health. 2019;19:1001.
- Caplan L. Delay in Breast Cancer: Implication for Stage at Diagnosis and Survival. Front Public Health. 2014;2:87.
- Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol. 2012:8.
- Khan MA, Shafique S, Khan MT, Shahzad MF, Iqbal S. Presentation delay in breast cancer patients, identifying the barriers in North Pakistan. Asian Pac J Cancer Prev. 2015; 16(1): 377-80.
- Akhtar M, Akulwar V, Gandhi D, Chandak K. Is locally advanced breast cancer a neglected disease? Indian J Cancer. 2011; 48(4): 403-5.
- Igene H. Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J. 2008; 14(5):428-34.
- Khan TM, Leong JPY, Ming LC, Khan AH. Association of knowledge and cultural perception of Malaysian women with delay in diagnosis and treatment of breast cancer: a systematic review. Asian Pac J Cancer Prev. 2015; 16(13):5349-57.
- Koh J, Kim MJ. Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage. Korean J Radiol. 2019; 20(1):69-82.
- American Cancer Society. Breast Cancer Stages [Internet]. Georgia, USA: American Cancer Society; 2019 [updated 2019 September; cited 2019 July 10]. Available from: https://www. cancer.org/cancer/breast-cancer/understanding-a-breast-cancer- diagnosis/stages-of-breast-cancer.html
- Breast Cancer.org. Breast Cancer Stage [Internet]. Pennsylvania USA: Breast Cancer.org; 2019 [updated 2019 July 23; cited
Aug 5]. Available from: https://www.breastcancer
.org/symptoms/diagnosis/staging
- Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001;91(1):178-88.
- Cianfrocca M, Gradishar W. New molecular classifications of breast cancer. CA Cancer J Clin. 2009;59(5):303-13.
- Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications.World J ClinOncol. 2014;5(3):412-24.
- Wang L. Early Diagnosis of Breast Cancer. Sensors (Basel).
;17(7):1572.
- Tabar L, Dean PB, Chen TH, Yen AM, Chen SL, Fann JC, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2018; 125(4): [preceding p.1].
- Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst. 2001; 93(13):
–89.
- Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992; 22(3):207–19.
- Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009; 20(8): 1319–29.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Suha Zubairi, Hassan Mirza, Aisha Qamar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
